Skip to main content

Table 2 Treatment characteristics

From: Prognostic factors in nasopharyngeal carcinoma with synchronous liver metastasis: a retrospective study for the management of treatment

Characteristics N (%)
Receiving treatment
 Yes 78 (91.7)
 No 7 (8.3)
Radiotherapy of primary tumor
 Yes 32 (37.6)
 No 53 (62.4)
Cycles of chemotherapy
 0 7 (8.2)
 1-5 36 (42.3)
 ≥6 42 (49.4)
Chemotherapy regimen
 PF 42 (53.8)
 TPF 21 (26.9)
 TP 15 (19.2)
Local therapy of metastatic lesions
 Yes 18 (21.1)
 RFA 13
 Embolization 4
 Radiotherapy 1
 No 67 (78.9)
Response to chemotherapy
Yes 52 (70.3)
 No 22 (29.7)
 No data 11
  1. PF: Cisplatin + 5-Fu; TPF: Cisplatin + 5-Fu + Paclitaxel; TP: Cisplatin + Paclitaxe;RFA: Radiofrequency ablation.